Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A04248 | Pages: 250 | Charts: 55 | Tables: 107 |
The global 3D medical imaging services market was valued at $207,134.9 million in 2020, and is projected to reach $377,062.6 million by 2030, registering a CAGR of 6.6% from 2021 to 2030. The major factors that drive the growth of the global 3D medical imaging services market include increase in need for point-of-care imaging system and surge in demand for optical imaging for better diagnosis of diseases and disorders. Furthermore, rise in incidence of chronic diseases and advancements in 3D medical imaging are expected to fuel the market growth. For instance, in 2020, as per the Global Cancer Observatory, an interactive web-based platform, it was reported that second most common cancer in Europe with estimated 477,534 newly diagnosed patients.
[COVIDIMPACTSTATEMENT]
3D medical imaging is a revolutionary optical imaging technology, which provides enlarged image of the interior body for medical analysis by utilizing 3D imaging modalities. The 3D imaging technology includes ultrasound, magnetic resonance imaging (MRI), radiography, and computed tomography scan (CT). 3D imaging plays a vital role in diagnosis of serious diseases such as oncology, cardiology, and orthopedics. 3D medical imaging system helps a surgeon to visualize clear picture of the anatomy and analyze the pathophysiology of a disease.
Get more information on this report : Request Sample Pages
Increase in prevalence of cardiac diseases drives the growth of the 3D medical imaging services market. The 3D imaging system such as radionuclide imaging, ultrasound, optical imaging, and CT scan are used in diagnosis of cardiac disorders to maximize diagnosis accuracy and enhance patient care. For instance, according to the World Health Organization (WHO), in June 2021, it was observed that cardiovascular diseases (CVDs) are the leading cause of death across the globe. In addition, increase in number of hospitals &diagnostics centers, and initiatives taken by government and private organizations to develop medical sectors drive the growth of market.
Furthermore, increase in R&D activities in 3D imaging technology, increase in number of 3D medical imaging devices, and rise in number of approval for products boosts the growth of the market. For instance, in April, 2021, Canon Medical Systems USA, Inc., a leading developer of medical devices, announced the U.S. Food and Drug Administration (FDA) approval for One-Beat Spectral Cardiac CT for cardiovascular imaging.
Moreover, increase in number of key players to develop innovative technologies and new product launches in the global market are anticipated to contribute toward the growth of the market. For instance, in November, 2021, Canon Medical Systems USA, Inc., a leading manufacturer of diagnostic devices, announced the launch of Vantage Fortian, which is an innovative remote tablet and in-room camera solutions for monitoring and positioning patients to enhance workflow. However, high cost of 3D medical imaging technology and unfavorable reimbursement scenario hamper the growth of the market.
The 3D medical imaging services market is segmented on the basis of techniques, application, and region. By techniques, the market is categorized into ultrasound, X-ray, MRI, and others. The X-ray segment is classified into radiography, computed tomography and fluoroscopy. The other segment, is classified into positron emission tomography (PET), single-photon emission computed tomography (SPECT), hybrid imaging, and medical photography. Depending on application, it is categorized in oncology, cardiology, orthopedic, and others.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Arabia, South Africa, and LAMEA).
[TECHNIQUESGRAPH]
According to technique, the MRI segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to advancements in MRI technology. However, the ultrasound segment is expected to witness considerable growth during the forecast period, owing to advancement in technology in medical healthcare sector and multiple advantages offered by 3D ultrasound imaging compared to traditional ultrasound imaging.
As per the application, the oncology segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to rise in prevalence of cancer and increase in demand for early diagnosis. However, the cardiology segment is expected to witness considerable growth during the forecast period, due to increase in prevalence of cardiovascular disease, rise in geriatric population, and rise in sedentary lifestyle.
[APPLICATIONGRAPH]
Region wise, North America garnered the major share in the 3D medical imaging services market in 2020, and is expected to dominate the global market during the forecast period, owing to rise in prevalence of chronic diseases, presence of key players for development of 3D medical imaging services, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR of 7.6% from 2021 to 2030, owing to increase in the number of hospitals, surge in demand for early diagnosis, rise in prevalence of cancer, cardiac disease, and increase in number of geriatric population.
The key players operating in the global 3D medical imaging services market include Accurate imaging Inc., Atlantic Medical Imaging Inc., Cobalt Health, Digirad Corporation, Del Medical Systems Group, Inc., Front Range Mobile Imaging Inc., Inhealth Group Ltd., RadNet Inc., Teleradiology Solutions, and Trident USA Health Services.
[REGIONGRAPH]
Key Benefits For Stakeholders
Key Market Segments
CHAPTER 1:INTRODUCTION
1.1.Report Description
1.2.Key Market Segments
1.3.Key Benefits
1.4.Research Methodology
1.4.1.Primary Research
1.4.2.Secondary Research
1.4.3.Analyst Tools and Models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO Perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market Definition and Scope
3.2.Key Findings
3.2.1.Top Investment Pockets
3.2.2.Top Winning Strategies
3.3.Porter's Five Forces Analysis
3.3.1.Bargaining Power of Suppliers
3.3.2.Threat of New Entrants
3.3.3.Threat of Substitutes
3.3.4.Competitive Rivalry
3.3.5.Bargaining Power among Buyers
3.4.Market Share Analysis/Top Player Positioning
3.4.1.Market Share Analysis/Top Player Positioning 2020
3.5.Market Dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis
CHAPTER 4:3D MEDICAL IMAGING SERVICES MARKET, BY TECHNIQUES
4.1.Market Overview
4.1.1Market Size and Forecast, By Techniques
4.2.Ultrasound
4.2.1.Key Market Trends, Growth Factors and Opportunities
4.2.2.Market Size and Forecast, By Region
4.2.3.Market Share Analysis, By Country
4.3.X-ray
4.3.1.Key Market Trends, Growth Factors and Opportunities
4.3.2.Market Size and Forecast, By Region
4.3.3.Market Share Analysis, By Country
4.3.4.Radiography
4.3.4.1.Market Size and Forecast
4.3.5.Computed tomography
4.3.5.1.Market Size and Forecast
4.3.6.Fluoroscopy
4.3.6.1.Market Size and Forecast
4.4.MRI
4.4.1.Key Market Trends, Growth Factors and Opportunities
4.4.2.Market Size and Forecast, By Region
4.4.3.Market Share Analysis, By Country
4.5.Others
4.5.1.Key Market Trends, Growth Factors and Opportunities
4.5.2.Market Size and Forecast, By Region
4.5.3.Market Share Analysis, By Country
4.5.4.Positron emission tomography (PET)
4.5.4.1.Market Size and Forecast
4.5.5.Single-photon emission computed tomography (SPECT)
4.5.5.1.Market Size and Forecast
4.5.6.Hybrid imaging
4.5.6.1.Market Size and Forecast
4.5.7.Medical photography
4.5.7.1.Market Size and Forecast
CHAPTER 5:3D MEDICAL IMAGING SERVICES MARKET, BY APPLICATION
5.1.Market Overview
5.1.1Market Size and Forecast, By Application
5.2.Oncology
5.2.1.Key Market Trends, Growth Factors and Opportunities
5.2.2.Market Size and Forecast, By Region
5.2.3.Market Share Analysis, By Country
5.3.Cardiology
5.3.1.Key Market Trends, Growth Factors and Opportunities
5.3.2.Market Size and Forecast, By Region
5.3.3.Market Share Analysis, By Country
5.4.Orthopedic
5.4.1.Key Market Trends, Growth Factors and Opportunities
5.4.2.Market Size and Forecast, By Region
5.4.3.Market Share Analysis, By Country
5.5.Others
5.5.1.Key Market Trends, Growth Factors and Opportunities
5.5.2.Market Size and Forecast, By Region
5.5.3.Market Share Analysis, By Country
CHAPTER 6:3D MEDICAL IMAGING SERVICES MARKET, BY REGION
6.1.Market Overview
6.1.1Market Size and Forecast, By Region
6.2.LAMEA
6.2.1.Key Market Trends and Opportunities
6.2.2.Market Size and Forecast, By Techniques
6.2.3.Market Size and Forecast, By Application
6.2.4.Market Size and Forecast, By Country
6.2.5.Brazil 3D Medical Imaging Services Market
6.2.5.1.Market Size and Forecast, By Techniques
6.2.5.2.Market Size and Forecast, By Application
6.2.6.South Africa, 3D Medical Imaging Services Market
6.2.6.1.Market Size and Forecast, By Techniques
6.2.6.2.Market Size and Forecast, By Application
6.2.7.Saudi Arabia 3D Medical Imaging Services Market
6.2.7.1.Market Size and Forecast, By Techniques
6.2.7.2.Market Size and Forecast, By Application
6.2.8.Turkey 3D Medical Imaging Services Market
6.2.8.1.Market Size and Forecast, By Techniques
6.2.8.2.Market Size and Forecast, By Application
6.2.9.Rest of LAMEA 3D Medical Imaging Services Market
6.2.9.1.Market Size and Forecast, By Techniques
6.2.9.2.Market Size and Forecast, By Application
6.3.North America
6.3.1.Key Market Trends and Opportunities
6.3.2.Market Size and Forecast, By Techniques
6.3.3.Market Size and Forecast, By Application
6.3.4.Market Size and Forecast, By Country
6.3.5.United States 3D Medical Imaging Services Market
6.3.5.1.Market Size and Forecast, By Techniques
6.3.5.2.Market Size and Forecast, By Application
6.3.6.Canada 3D Medical Imaging Services Market
6.3.6.1.Market Size and Forecast, By Techniques
6.3.6.2.Market Size and Forecast, By Application
6.3.7.Mexico 3D Medical Imaging Services Market
6.3.7.1.Market Size and Forecast, By Techniques
6.3.7.2.Market Size and Forecast, By Application
6.4.Europe
6.4.1.Key Market Trends and Opportunities
6.4.2.Market Size and Forecast, By Techniques
6.4.3.Market Size and Forecast, By Application
6.4.4.Market Size and Forecast, By Country
6.4.5.France 3D Medical Imaging Services Market
6.4.5.1.Market Size and Forecast, By Techniques
6.4.5.2.Market Size and Forecast, By Application
6.4.6.Germany 3D Medical Imaging Services Market
6.4.6.1.Market Size and Forecast, By Techniques
6.4.6.2.Market Size and Forecast, By Application
6.4.7.Spain 3D Medical Imaging Services Market
6.4.7.1.Market Size and Forecast, By Techniques
6.4.7.2.Market Size and Forecast, By Application
6.4.8.U.K 3D Medical Imaging Services Market
6.4.8.1.Market Size and Forecast, By Techniques
6.4.8.2.Market Size and Forecast, By Application
6.4.9.Rest Of Europe 3D Medical Imaging Services Market
6.4.9.1.Market Size and Forecast, By Techniques
6.4.9.2.Market Size and Forecast, By Application
6.5.Asia-Pacific
6.5.1.Key Market Trends and Opportunities
6.5.2.Market Size and Forecast, By Techniques
6.5.3.Market Size and Forecast, By Application
6.5.4.Market Size and Forecast, By Country
6.5.5.China 3D Medical Imaging Services Market
6.5.5.1.Market Size and Forecast, By Techniques
6.5.5.2.Market Size and Forecast, By Application
6.5.6.Japan 3D Medical Imaging Services Market
6.5.6.1.Market Size and Forecast, By Techniques
6.5.6.2.Market Size and Forecast, By Application
6.5.7.India 3D Medical Imaging Services Market
6.5.7.1.Market Size and Forecast, By Techniques
6.5.7.2.Market Size and Forecast, By Application
6.5.8.Australia 3D Medical Imaging Services Market
6.5.8.1.Market Size and Forecast, By Techniques
6.5.8.2.Market Size and Forecast, By Application
6.5.9.Malaysia 3D Medical Imaging Services Market
6.5.9.1.Market Size and Forecast, By Techniques
6.5.9.2.Market Size and Forecast, By Application
6.5.10.Rest of Asia Pacific 3D Medical Imaging Services Market
6.5.10.1.Market Size and Forecast, By Techniques
6.5.10.2.Market Size and Forecast, By Application
CHAPTER 7:COMPANY PROFILES
7.1.Accurate Imaging Inc.
7.1.1.Company Overview
7.1.2.Key Executives
7.1.3.Company snapshot
7.1.4.Operating business segments
7.1.5.Product portfolio
7.1.6.Business Performance
7.1.7.Key Strategic Moves and Developments
7.2.Atlantic Medical Imaging Inc
7.2.1.Company Overview
7.2.2.Key Executives
7.2.3.Company snapshot
7.2.4.Operating business segments
7.2.5.Product portfolio
7.2.6.Business Performance
7.2.7.Key Strategic Moves and Developments
7.3.Cobalt Health
7.3.1.Company Overview
7.3.2.Key Executives
7.3.3.Company snapshot
7.3.4.Operating business segments
7.3.5.Product portfolio
7.3.6.Business Performance
7.3.7.Key Strategic Moves and Developments
7.4.Digirad Corporation
7.4.1.Company Overview
7.4.2.Key Executives
7.4.3.Company snapshot
7.4.4.Operating business segments
7.4.5.Product portfolio
7.4.6.Business Performance
7.4.7.Key Strategic Moves and Developments
7.5.Del Medical Systems Group, Inc.
7.5.1.Company Overview
7.5.2.Key Executives
7.5.3.Company snapshot
7.5.4.Operating business segments
7.5.5.Product portfolio
7.5.6.Business Performance
7.5.7.Key Strategic Moves and Developments
7.6.Front Range Mobile Imaging Inc.
7.6.1.Company Overview
7.6.2.Key Executives
7.6.3.Company snapshot
7.6.4.Operating business segments
7.6.5.Product portfolio
7.6.6.Business Performance
7.6.7.Key Strategic Moves and Developments
7.7.Inhealth Group Ltd.
7.7.1.Company Overview
7.7.2.Key Executives
7.7.3.Company snapshot
7.7.4.Operating business segments
7.7.5.Product portfolio
7.7.6.Business Performance
7.7.7.Key Strategic Moves and Developments
7.8.RadNet Inc.
7.8.1.Company Overview
7.8.2.Key Executives
7.8.3.Company snapshot
7.8.4.Operating business segments
7.8.5.Product portfolio
7.8.6.Business Performance
7.8.7.Key Strategic Moves and Developments
7.9.Teleradiology Solutions
7.9.1.Company Overview
7.9.2.Key Executives
7.9.3.Company snapshot
7.9.4.Operating business segments
7.9.5.Product portfolio
7.9.6.Business Performance
7.9.7.Key Strategic Moves and Developments
7.10.Trident USA Health Services
7.10.1.Company Overview
7.10.2.Key Executives
7.10.3.Company snapshot
7.10.4.Operating business segments
7.10.5.Product portfolio
7.10.6.Business Performance
7.10.7.Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 2.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET FOR ULTRASOUND, BY REGION, 2020-2030 ($MILLION)
TABLE 3.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET FOR X-RAY, BY REGION, 2020-2030 ($MILLION)
TABLE 4.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET FOR MRI, BY REGION, 2020-2030 ($MILLION)
TABLE 5.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 6.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 7.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET FOR ONCOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 8.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET FOR CARDIOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 9.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET FOR ORTHOPEDIC, BY REGION, 2020-2030 ($MILLION)
TABLE 10.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 11.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 12.LAMEA 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 13.LAMEA 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 14.BRAZIL 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 15.BRAZIL 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 16.SOUTH AFRICA, 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 17.SOUTH AFRICA, 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 18.SAUDI ARABIA 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 19.SAUDI ARABIA 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 20.TURKEY 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 21.TURKEY 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 22.REST OF LAMEA 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 23.REST OF LAMEA 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 24.NORTH AMERICA 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 25.NORTH AMERICA 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 26.UNITED STATES 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 27.UNITED STATES 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 28.CANADA 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 29.CANADA 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 30.MEXICO 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 31.MEXICO 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 32.EUROPE 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 33.EUROPE 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 34.FRANCE 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 35.FRANCE 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 36.GERMANY 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 37.GERMANY 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 38.SPAIN 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 39.SPAIN 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 40.UNITED KINGDOM 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 41.UNITED KINGDOM 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 42.REST OF EUROPE 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 43.REST OF EUROPE 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 44.ASIA-PACIFIC 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 45.ASIA-PACIFIC 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 46.CHINA 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 47.CHINA 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 48.JAPAN 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 49.JAPAN 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 50.INDIA 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 51.INDIA 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 52.AUSTRALIA 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 53.AUSTRALIA 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 54.MALAYSIA 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 55.MALAYSIA 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 56.REST OF ASIA PACIFIC 3D MEDICAL IMAGING SERVICES, BY TECHNIQUES, 2020-2030 ($MILLION)
TABLE 57.REST OF ASIA PACIFIC 3D MEDICAL IMAGING SERVICES, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 58.ACCURATE IMAGING INC.: KEY EXECUTIVES
TABLE 59.ACCURATE IMAGING INC.: COMPANY SNAPSHOT
TABLE 60.ACCURATE IMAGING INC.: OPERATING SEGMENTS
TABLE 61.ACCURATE IMAGING INC.: PRODUCT PORTFOLIO
TABLE 62.ACCURATE IMAGING INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 63.ATLANTIC MEDICAL IMAGING INC: KEY EXECUTIVES
TABLE 64.ATLANTIC MEDICAL IMAGING INC: COMPANY SNAPSHOT
TABLE 65.ATLANTIC MEDICAL IMAGING INC: OPERATING SEGMENTS
TABLE 66.ATLANTIC MEDICAL IMAGING INC: PRODUCT PORTFOLIO
TABLE 67.ATLANTIC MEDICAL IMAGING INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 68.COBALT HEALTH: KEY EXECUTIVES
TABLE 69.COBALT HEALTH: COMPANY SNAPSHOT
TABLE 70.COBALT HEALTH: OPERATING SEGMENTS
TABLE 71.COBALT HEALTH: PRODUCT PORTFOLIO
TABLE 72.COBALT HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 73.DIGIRAD CORPORATION: KEY EXECUTIVES
TABLE 74.DIGIRAD CORPORATION: COMPANY SNAPSHOT
TABLE 75.DIGIRAD CORPORATION: OPERATING SEGMENTS
TABLE 76.DIGIRAD CORPORATION: PRODUCT PORTFOLIO
TABLE 77.DIGIRAD CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 78.DEL MEDICAL SYSTEMS GROUP, INC.: KEY EXECUTIVES
TABLE 79.DEL MEDICAL SYSTEMS GROUP, INC.: COMPANY SNAPSHOT
TABLE 80.DEL MEDICAL SYSTEMS GROUP, INC.: OPERATING SEGMENTS
TABLE 81.DEL MEDICAL SYSTEMS GROUP, INC.: PRODUCT PORTFOLIO
TABLE 82.DEL MEDICAL SYSTEMS GROUP, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 83.FRONT RANGE MOBILE IMAGING INC.: KEY EXECUTIVES
TABLE 84.FRONT RANGE MOBILE IMAGING INC.: COMPANY SNAPSHOT
TABLE 85.FRONT RANGE MOBILE IMAGING INC.: OPERATING SEGMENTS
TABLE 86.FRONT RANGE MOBILE IMAGING INC.: PRODUCT PORTFOLIO
TABLE 87.FRONT RANGE MOBILE IMAGING INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 88.INHEALTH GROUP LTD.: KEY EXECUTIVES
TABLE 89.INHEALTH GROUP LTD.: COMPANY SNAPSHOT
TABLE 90.INHEALTH GROUP LTD.: OPERATING SEGMENTS
TABLE 91.INHEALTH GROUP LTD.: PRODUCT PORTFOLIO
TABLE 92.INHEALTH GROUP LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 93.RADNET INC.: KEY EXECUTIVES
TABLE 94.RADNET INC.: COMPANY SNAPSHOT
TABLE 95.RADNET INC.: OPERATING SEGMENTS
TABLE 96.RADNET INC.: PRODUCT PORTFOLIO
TABLE 97.RADNET INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 98.TELERADIOLOGY SOLUTIONS: KEY EXECUTIVES
TABLE 99.TELERADIOLOGY SOLUTIONS: COMPANY SNAPSHOT
TABLE 100.TELERADIOLOGY SOLUTIONS: OPERATING SEGMENTS
TABLE 101.TELERADIOLOGY SOLUTIONS: PRODUCT PORTFOLIO
TABLE 102.TELERADIOLOGY SOLUTIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103.TRIDENT USA HEALTH SERVICES: KEY EXECUTIVES
TABLE 104.TRIDENT USA HEALTH SERVICES: COMPANY SNAPSHOT
TABLE 105.TRIDENT USA HEALTH SERVICES: OPERATING SEGMENTS
TABLE 106.TRIDENT USA HEALTH SERVICES: PRODUCT PORTFOLIO
TABLE 107.TRIDENT USA HEALTH SERVICES: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET SEGMENTATION
FIGURE 2.GLOBAL 3D MEDICAL IMAGING SERVICES MARKET
FIGURE 3.SEGMENTATION 3D MEDICAL IMAGING SERVICES MARKET
FIGURE 4.TOP INVESTMENT POCKET IN 3D MEDICAL IMAGING SERVICES MARKET
FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
FIGURE 11.LOW THREAT OF SUBSTITUTION
FIGURE 12.HIGH COMPETITIVE RIVALRY
FIGURE 13.TOP PLAYER POSITIONING, 2020
FIGURE 14.MARKET SHARE ANALYSIS, 2020
FIGURE 15.RESTRAINTS AND DRIVERS: 3D MEDICAL IMAGING SERVICES MARKET
FIGURE 16.3D MEDICAL IMAGING SERVICES MARKET SEGMENTATION, BY TECHNIQUES
FIGURE 17.3D MEDICAL IMAGING SERVICES MARKET FOR ULTRASOUND, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 18.3D MEDICAL IMAGING SERVICES MARKET FOR X-RAY, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 19.3D MEDICAL IMAGING SERVICES MARKET FOR MRI, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 20.3D MEDICAL IMAGING SERVICES MARKET FOR OTHERS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 21.3D MEDICAL IMAGING SERVICES MARKET SEGMENTATION, BY APPLICATION
FIGURE 22.3D MEDICAL IMAGING SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 23.3D MEDICAL IMAGING SERVICES MARKET FOR CARDIOLOGY, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 24.3D MEDICAL IMAGING SERVICES MARKET FOR ORTHOPEDIC, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 25.3D MEDICAL IMAGING SERVICES MARKET FOR OTHERS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 26.ACCURATE IMAGING INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 27.ACCURATE IMAGING INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 28.ACCURATE IMAGING INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 29.ATLANTIC MEDICAL IMAGING INC: NET SALES, 2018-2020 ($MILLION)
FIGURE 30.ATLANTIC MEDICAL IMAGING INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 31.ATLANTIC MEDICAL IMAGING INC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 32.COBALT HEALTH: NET SALES, 2018-2020 ($MILLION)
FIGURE 33.COBALT HEALTH: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 34.COBALT HEALTH: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 35.DIGIRAD CORPORATION: NET SALES, 2018-2020 ($MILLION)
FIGURE 36.DIGIRAD CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 37.DIGIRAD CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 38.DEL MEDICAL SYSTEMS GROUP, INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 39.DEL MEDICAL SYSTEMS GROUP, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 40.DEL MEDICAL SYSTEMS GROUP, INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 41.FRONT RANGE MOBILE IMAGING INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 42.FRONT RANGE MOBILE IMAGING INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 43.FRONT RANGE MOBILE IMAGING INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 44.INHEALTH GROUP LTD.: NET SALES, 2018-2020 ($MILLION)
FIGURE 45.INHEALTH GROUP LTD.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 46.INHEALTH GROUP LTD.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 47.RADNET INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 48.RADNET INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 49.RADNET INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 50.TELERADIOLOGY SOLUTIONS: NET SALES, 2018-2020 ($MILLION)
FIGURE 51.TELERADIOLOGY SOLUTIONS: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 52.TELERADIOLOGY SOLUTIONS: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 53.TRIDENT USA HEALTH SERVICES: NET SALES, 2018-2020 ($MILLION)
FIGURE 54.TRIDENT USA HEALTH SERVICES: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 55.TRIDENT USA HEALTH SERVICES: REVENUE SHARE, BY REGION, 2020 (%)